For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
High value, huge potential of those who give most of the care, most of the time
+Print Archive
Bulletin
High value, huge potential of those who give most of the care, most of the time
Wednesday 21 October 2020, 12:00 AM

Jeff Lowe
General Practice NZ
Just prior to last weekend’s election, General Practice New Zealand pondered its message for the next health minister, whoever they might be. Jeff Lowe reports
Better care and better outcomes start with the components of sustainable general practice
Little attention was paid in the election campaign to w
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.